Evidence map

ArticleKidney international2025

Fibroblast growth factor 23 and fibroblast growth factor receptor 4 promote cardiac metabolic remodeling in chronic kidney disease.

Michaela A A Fuchs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

16 papers cite it

2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 39923962